Diagnosis and Stratification of


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2021
Historique:
received: 08 10 2021
accepted: 12 11 2021
entrez: 31 12 2021
pubmed: 1 1 2022
medline: 29 1 2022
Statut: epublish

Résumé

The development of a highly sensitive, specific, and reliable immunochemical assay to detect pyocyanin (PYO), one of the most important virulence factors (VFs) of

Identifiants

pubmed: 34970510
doi: 10.3389/fcimb.2021.786929
pmc: PMC8712664
doi:

Substances chimiques

Virulence Factors 0
Pyocyanine 9OQM399341

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

786929

Informations de copyright

Copyright © 2021 Rodriguez-Urretavizcaya, Pascual, Pastells, Martin-Gomez, Vilaplana and Marco.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Appl Microbiol Biotechnol. 2019 Apr;103(8):3521-3535
pubmed: 30852658
Sci Rep. 2018 Jan 18;8(1):1155
pubmed: 29348452
Braz J Microbiol. 2019 Oct;50(4):979-984
pubmed: 31352634
Pharmacotherapy. 2020 Sep;40(9):952-969
pubmed: 32696452
Cytotherapy. 2017 Dec;19(12):1509-1521
pubmed: 29037942
PLoS One. 2014 May 22;9(5):e96166
pubmed: 24852379
PLoS One. 2018 Sep 13;13(9):e0204167
pubmed: 30212579
J Biotechnol. 2014 Dec 10;191:121-30
pubmed: 25240440
Nature. 1956 Oct 6;178(4536):753
pubmed: 13369535
Biosens Bioelectron. 2017 Nov 15;97:65-69
pubmed: 28570940
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7481-6
pubmed: 21518885
Free Radic Biol Med. 2004 Jun 1;36(11):1448-59
pubmed: 15135182
DNA Cell Biol. 2002 May-Jun;21(5-6):415-20
pubmed: 12167244
Proc Natl Acad Sci U S A. 2006 May 30;103(22):8487-92
pubmed: 16687478
Sci Rep. 2019 Aug 15;9(1):11929
pubmed: 31417101
Eur Respir J. 2019 Apr 11;53(4):
pubmed: 30635292
Front Immunol. 2018 Oct 22;9:2416
pubmed: 30405616
Front Microbiol. 2011 Jul 13;2:150
pubmed: 21808635
J Nat Med. 2018 Jan;72(1):32-42
pubmed: 29164507
Curr Opin Microbiol. 2018 Feb;41:15-20
pubmed: 29166621
MAbs. 2012 Jul-Aug;4(4):445-57
pubmed: 22684311
Infect Immun. 1988 Sep;56(9):2515-7
pubmed: 3137173
J Clin Virol. 2019 Nov;120:38-43
pubmed: 31546089
J Biomed Sci. 2020 Jan 2;27(1):1
pubmed: 31894001
J Bacteriol. 2008 Dec;190(24):7910-7
pubmed: 18849421
Trends Microbiol. 2011 Aug;19(8):419-26
pubmed: 21664819
Toxins (Basel). 2016 Aug 09;8(8):
pubmed: 27517959
Appl Spectrosc. 2017 Feb;71(2):215-223
pubmed: 27354400
Trends Biotechnol. 2019 Jan;37(1):9-16
pubmed: 29945725
Biosens Bioelectron. 2015 Feb 15;64:25-9
pubmed: 25173735
Anal Bioanal Chem. 2020 Sep;412(24):5897-5912
pubmed: 32462363
Mol Microbiol. 2017 Dec;106(6):976-985
pubmed: 29030956
Acta Paediatr. 2020 May;109(5):893-899
pubmed: 31899933
Nat Rev Microbiol. 2015 Jan;13(1):42-51
pubmed: 25435309
BMC Infect Dis. 2012 Nov 16;12:308
pubmed: 23157735
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14315-20
pubmed: 14605211
J Bacteriol. 2006 Feb;188(4):1211-7
pubmed: 16452401
Biotechnol Adv. 2019 Jan - Feb;37(1):177-192
pubmed: 30500353
Curr Opin Pulm Med. 2013 May;19(3):216-28
pubmed: 23524477
Acta Otolaryngol Suppl. 2000;543:86-8
pubmed: 10908987
J Nanobiotechnology. 2019 Sep 16;17(1):96
pubmed: 31526383
FEMS Microbiol Rev. 2017 May 1;41(3):219-251
pubmed: 28333307
Anal Chem. 2021 Mar 23;93(11):4859-4866
pubmed: 33691411
Mol Microbiol. 2007 Apr;64(2):512-33
pubmed: 17493132
Sensors (Basel). 2017 Jul 25;17(8):
pubmed: 28757555
Paediatr Respir Rev. 2002 Jun;3(2):115-9
pubmed: 12297057
Anal Chem. 2016 Feb 2;88(3):1631-8
pubmed: 26738983
PLoS One. 2018 Mar 22;13(3):e0194157
pubmed: 29566025
Mol Microbiol. 2018 Dec;110(6):995-1010
pubmed: 30230061
Br J Exp Pathol. 1953 Dec;34(6):583-7
pubmed: 13115587
Front Microbiol. 2018 Jul 17;9:1354
pubmed: 30065702
Clin Infect Dis. 2005 Sep 15;41(6):848-54
pubmed: 16107985
ACS Infect Dis. 2020 Dec 11;6(12):3237-3246
pubmed: 33210530
Clin Infect Dis. 2009 Jan 1;48(1):1-12
pubmed: 19035777
Respirology. 2010 Oct;15(7):1037-56
pubmed: 20723140
J Bacteriol. 2019 Feb 11;201(5):
pubmed: 30530517
J Bacteriol. 2002 Dec;184(23):6481-9
pubmed: 12426335
Am J Respir Crit Care Med. 2005 Jun 1;171(11):1209-23
pubmed: 15695491
Expert Rev Pharmacoecon Outcomes Res. 2010 Aug;10(4):441-51
pubmed: 20715920
mBio. 2015 Oct 27;6(6):e01520-15
pubmed: 26507234
Front Cell Infect Microbiol. 2019 May 31;9:182
pubmed: 31214514
World J Microbiol Biotechnol. 2014 Apr;30(4):1159-68
pubmed: 24214679
Oman Med J. 2017 Mar;32(2):167-169
pubmed: 28439390
Mol Microbiol. 2006 Sep;61(5):1308-21
pubmed: 16879411

Auteurs

Barbara Rodriguez-Urretavizcaya (B)

Nanobiotechnology for Diagnostics (Nb4D), Institute of Advanced Chemistry of Catalonia, Institute for Advanced Chemistry of Catalonia (IQAC)-Spanish National Research Council (CSIC), Barcelona, Spain.
Centro de Investigación Biomédica en Red (CIBER) de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.

Nuria Pascual (N)

Nanobiotechnology for Diagnostics (Nb4D), Institute of Advanced Chemistry of Catalonia, Institute for Advanced Chemistry of Catalonia (IQAC)-Spanish National Research Council (CSIC), Barcelona, Spain.
Centro de Investigación Biomédica en Red (CIBER) de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.

Carme Pastells (C)

Nanobiotechnology for Diagnostics (Nb4D), Institute of Advanced Chemistry of Catalonia, Institute for Advanced Chemistry of Catalonia (IQAC)-Spanish National Research Council (CSIC), Barcelona, Spain.
Centro de Investigación Biomédica en Red (CIBER) de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.

Maria Teresa Martin-Gomez (MT)

Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Lluïsa Vilaplana (L)

Nanobiotechnology for Diagnostics (Nb4D), Institute of Advanced Chemistry of Catalonia, Institute for Advanced Chemistry of Catalonia (IQAC)-Spanish National Research Council (CSIC), Barcelona, Spain.
Centro de Investigación Biomédica en Red (CIBER) de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.

Maria-Pilar Marco (MP)

Nanobiotechnology for Diagnostics (Nb4D), Institute of Advanced Chemistry of Catalonia, Institute for Advanced Chemistry of Catalonia (IQAC)-Spanish National Research Council (CSIC), Barcelona, Spain.
Centro de Investigación Biomédica en Red (CIBER) de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH